The results showed a significant increase in CD68 immunoreactivity in the CHOW + MC group compared to the lean control mice (CHOW) (*p < 0.05), and simultaneously a significant increase in NAFLD + MC mice compared to the NAFLD only group (*p < 0.05). The gene discussed is CD68; the disease is metabolic dysfunction-associated steatotic liver disease.